Filter
761
Filtered Results: 761
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
367
Studies & Reports
150
Guidelines
128
Manuals
44
Strategic & Response Plan
41
Fact sheets
12
Situation Updates
8
Training Material
5
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
36
Global
34
Kenya
32
Ghana
21
Nigeria
21
Uganda
19
Ethiopia
18
Western and Central Europe
14
South Africa
14
Sierra Leone
13
Tanzania
13
Bangladesh
13
Nepal
12
Zambia
12
Africa
10
Lesotho
9
Malawi
9
Botswana
9
Ukraine
8
Zimbabwe
8
Liberia
8
Rwanda
7
South–East Asia Region
7
Namibia
7
Myanmar / Burma
7
Philippines
6
Latin America and the Carribbean
6
Eastern Europe
5
Indonesia
5
Eswatini/ Swaziland
4
Tajikistan
3
Thailand
3
Albania
3
Haiti
3
Cambodia
3
West and Central Africa
3
East and Southern Africa
3
Russia
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
Asia
2
Germany
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Vietnam
2
Moldova
2
Sudan
2
Pakistan
2
Serbia
1
Australia
1
Benin
1
China
1
Syria
1
Burkina Faso
1
Uzbekistan
1
Mongolia
1
Guinea
1
USA
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Turkmenistan
1
Maldives
1
Mauritius
1
Brazil
1
Sri Lanka
1
South Sudan
1
Iraq
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
309
Clinical Guidelines
58
Pharmacy & Technologies
32
Public Health
27
Key Resources
20
Women & Child Health
13
Capacity Building
5
Toolboxes
Pharmacy
85
AMR
85
COVID-19
54
HIV
48
TB
38
Mental Health
34
NTDs
20
Malaria
19
Planetary Health
17
Rapid Response
14
Ebola & Marburg
14
NCDs
14
Health Financing Toolbox
12
Global Health Education
12
Specific Hazards
6
Caregiver
6
Conflict
5
Cholera
4
Natural Hazards
3
Polio
2
Refugee
1
Disability
1
Zika
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
A role for nuclear techniques
Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic...
Ce guide a été préparé par le Bureau des activités pour les employeurs (ACT/EMP) de l’Organisation internationale du Travail et contient des recommandations sur les mesures pratiques et les méthodes à mettre en oeuvre en matière de santé et de sécurité pour la prévention du COVID-19.
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...
The report aims to help policy-makers and programme managers identify the areas that need attention and to work towards effective implementation and enforcement of policies and legislations. The need for alcohol policy-specific infrastructures to support the alcohol policy process, including designa...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
2020 is a critical year for our Joint Programme as we collectively define the path to getting back on track to ending the AIDS epidemic by 2030. Our revised timelines for adoption of the next strategy are highly ambitious. We need the full support of all the tremendously dedicated people in UNAIDS-w...
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
